UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 257

Sortiert nach

Computation of the binding affinities of catechol-O-methyltransferase inhibitors: Multisubstate relative free energy calculations

Journal of computational chemistry, 2012-04, Vol.33 (9), p.970-986

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of zamicastat on blood pressure and heart rate response to cold pressor test: A double‐blind, randomized, placebo‐controlled study in healthy subjects

British journal of clinical pharmacology, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

chiral HPLC-UV method for the quantification of dibenz[b,f]azepine-5-carboxamide derivatives in mouse plasma and brain tissue: Eslicarbazepine acetate, carbamazepine and main metabolites

Journal of separation science, 2011-06, Vol.34 (12), p.1391-1401

2011

Link zum Volltext

Verfügbarkeit prüfen

Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats

The European journal of neuroscience, 2003-08, Vol.18 (4), p.820-828

2003

Link zum Volltext

Verfügbarkeit prüfen

Bioanalytical chromatographic methods for the determination of catechol- O-methyltransferase inhibitors in rodents and human samples: A review

Analytica chimica acta, 2012-01, Vol.710, p.17-32

2012

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study

Translational neurodegeneration, 2020-04, Vol.9 (1), p.14-14, Article 14

2020

Link zum Volltext

Verfügbarkeit prüfen

H2O2 stimulates Cl−/HCO 3− exchanger activity through oxidation of thiol groups in immortalized SHR renal proximal tubular epithelial cells

Journal of cellular biochemistry, 2011-12, Vol.112 (12), p.3660-3665

2011

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and structure–activity relationships of ionizable 1,3,4-oxadiazol-2(3H)-ones as peripherally selective FAAH inhibitors with improved aqueous solubility

Pure and applied chemistry, 2016-04, Vol.88 (4), p.341-347

2016

Link zum Volltext

Verfügbarkeit prüfen

An HPLC-DAD method for the simultaneous quantification of opicapone (BIA 9-1067) and its active metabolite in human plasma

Analyst (London), 2013-04, Vol.138 (8), p.2463-2469

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-term effect of Toll-like receptor-2, -4, -5, -7 and NOD2 stimulation on Na + ,K + -ATPase activity and expression in intestinal epithelial cells

American Journal of Physiology: Cell Physiology, 2023-05, Vol.324 (5), p.C1028-C1038

2023

Link zum Volltext

Verfügbarkeit prüfen

High- and low-affinity transport of L-leucine and L-DOPA by the hetero amino acid exchangers LAT1 and LAT2 in LLC-PK1 renal cells

American journal of physiology. Renal physiology, 2004-08, Vol.287 (2), p.F252-F261

2004

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Oxidative stress and the genomic regulation of aldosterone-stimulated NHE1 activity in SHR renal proximal tubular cells

Molecular and cellular biochemistry, 2011-11, Vol.357 (1-2), p.423-423

2011

Link zum Volltext

Verfügbarkeit prüfen

Short-term effect on intestinal epithelial Na+/H+ exchanger by Giα1,2-coupled 5-HT1A and Gq/11-coupled 5-HT2 receptors

Life sciences (1973), 2007-07, Vol.81 (7), p.560-569

2007

Link zum Volltext

Verfügbarkeit prüfen

The Chemistry of Catechol- O-Methyltransferase Inhibitors

Basic Aspects of Catechol-O-Methyltransferase and the Clinical Applications of Its Inhibitors, 2010, Vol.95, p.119-162

2010

Link zum Volltext

Verfügbarkeit prüfen

Role of H(2)O(2) on the kinetics of low-affinity high-capacity Na(+)-dependent alanine transport in SHR proximal tubular epithelial cells

Biochemical and biophysical research communications, 2010-07, Vol.398 (3), p.553-558

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of opicapone according to levodopa's duration of use in Parkinson's disease patients with motor fluctuations

Journal of the neurological sciences, 2021-10, Vol.429, p.119450, Article 119450

2021

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of entacapone: Findings from the real-world OPTIPARK study

Journal of the neurological sciences, 2021-10, Vol.429, p.119439, Article 119439

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term efficacy of opicapone in the reduction of on-time with troublesome dyskinesia in Parkinson's disease patients with motor fluctuations and reporting troublesome dyskinesia

Journal of the neurological sciences, 2021-10, Vol.429, p.119442, Article 119442

2021

Link zum Volltext

Verfügbarkeit prüfen

Opicapone in clinical practice in Parkinson's disease German patients with motor fluctuations: Findings from the OPTIPARK study

Journal of the neurological sciences, 2021-10, Vol.429, p.119429, Article 119429

2021

Link zum Volltext

Verfügbarkeit prüfen

Opicapone in clinical practice in Parkinson's disease patients with motor fluctuations and complications of therapy at baseline: Findings from the OPTIPARK study

Journal of the neurological sciences, 2021-10, Vol.429, p.119451, Article 119451

2021

Link zum Volltext

Verfügbarkeit prüfen

Influence of onset of motor fluctuations on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: Findings from the real-world OPTIPARK study

Journal of the neurological sciences, 2021-10, Vol.429, p.119425, Article 119425

2021

Link zum Volltext

Verfügbarkeit prüfen

Influence of disease duration on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: Findings from the real-world OPTIPARK study

Journal of the neurological sciences, 2021-10, Vol.429, p.119440, Article 119440

2021

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of dopamine agonists: Findings from the real-world OPTIPARK study

Journal of the neurological sciences, 2021-10, Vol.429, p.119432, Article 119432

2021

Link zum Volltext

Verfügbarkeit prüfen

Opicapone analysis of health economic costs in clinical practice in Parkinson's disease UK patients with motor fluctuations: Findings from the OPTIPARK study

Journal of the neurological sciences, 2021-10, Vol.429, p.119441, Article 119441

2021

Link zum Volltext

Verfügbarkeit prüfen

Opicapone in clinical practice in Parkinson's disease UK patients with motor fluctuations: Findings from the OPTIPARK study

Journal of the neurological sciences, 2021-10, Vol.429, p.119428, Article 119428

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 257

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(222)
Mit Volltextzugriff
(241)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Animals
(25)
Humans
(21)
Biological And Medical Sciences
(20)
Rats
(17)
Male
(16)
Hypertension
(12)
Fundamental And Applied Biological Sciences. Psychology
(11)
Medical Sciences
(10)
Dopamine
(9)
Neurology
(9)
Adult
(8)
Catechol O-Methyltransferase Inhibitors
(8)
Science & Technology
(8)
Dose-Response Relationship, Drug
(7)
Enzyme Inhibitors - Pharmacology
(7)
Rats, Wistar
(7)
Sodium-Hydrogen Exchangers - Metabolism
(7)
Catechol O-Methyltransferase - Metabolism
(6)
Chemistry
(6)
Kidney - Metabolism
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Computation of the binding affinities of catechol-O-methyltransferase inhibitors: Multisubstate relative free energy calculations

Effect of zamicastat on blood pressure and heart rate response to cold pressor test: A double‐blind, randomized, placebo‐controlled study in healthy subjects

chiral HPLC-UV method for the quantification of dibenz[b,f]azepine-5-carboxamide derivatives in mouse plasma and brain tissue: Eslicarbazepine acetate, carbamazepine and main metabolites

Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats

Bioanalytical chromatographic methods for the determination of catechol- O-methyltransferase inhibitors in rodents and human samples: A review

Correction to: Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study

H2O2 stimulates Cl−/HCO 3− exchanger activity through oxidation of thiol groups in immortalized SHR renal proximal tubular epithelial cells

Synthesis and structure–activity relationships of ionizable 1,3,4-oxadiazol-2(3H)-ones as peripherally selective FAAH inhibitors with improved aqueous solubility

An HPLC-DAD method for the simultaneous quantification of opicapone (BIA 9-1067) and its active metabolite in human plasma

Long-term effect of Toll-like receptor-2, -4, -5, -7 and NOD2 stimulation on Na + ,K + -ATPase activity and expression in intestinal epithelial cells

High- and low-affinity transport of L-leucine and L-DOPA by the hetero amino acid exchangers LAT1 and LAT2 in LLC-PK1 renal cells

Erratum to: Oxidative stress and the genomic regulation of aldosterone-stimulated NHE1 activity in SHR renal proximal tubular cells

Short-term effect on intestinal epithelial Na+/H+ exchanger by Giα1,2-coupled 5-HT1A and Gq/11-coupled 5-HT2 receptors

The Chemistry of Catechol- O-Methyltransferase Inhibitors

Role of H(2)O(2) on the kinetics of low-affinity high-capacity Na(+)-dependent alanine transport in SHR proximal tubular epithelial cells

Efficacy of opicapone according to levodopa's duration of use in Parkinson's disease patients with motor fluctuations

Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of entacapone: Findings from the real-world OPTIPARK study

Long-term efficacy of opicapone in the reduction of on-time with troublesome dyskinesia in Parkinson's disease patients with motor fluctuations and reporting troublesome dyskinesia

Opicapone in clinical practice in Parkinson's disease German patients with motor fluctuations: Findings from the OPTIPARK study

Opicapone in clinical practice in Parkinson's disease patients with motor fluctuations and complications of therapy at baseline: Findings from the OPTIPARK study

Influence of onset of motor fluctuations on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: Findings from the real-world OPTIPARK study

Influence of disease duration on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: Findings from the real-world OPTIPARK study

Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of dopamine agonists: Findings from the real-world OPTIPARK study

Opicapone analysis of health economic costs in clinical practice in Parkinson's disease UK patients with motor fluctuations: Findings from the OPTIPARK study

Opicapone in clinical practice in Parkinson's disease UK patients with motor fluctuations: Findings from the OPTIPARK study

Aktive Filter

Suchergebnisse filtern